
|Videos|June 26, 2021
Dr. Ariana Matz on trends in priapism malpractice litigation
Author(s)Urology Times staff
“We found that medications allegedly causing priapism and the litigation surrounding that is significant because it means that the patient-physician relationship was not well established,” says Ariana Matz, MD.
Advertisement
In this video, Ariana Matz, MD, of New York Medical College, Valhalla, discusses the Urology study, “Review of priapism litigation in the United States,” for which she served as a study author.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
4
FDA approves first-line Zenflow system for the treatment of BPH
5


















